Comparison

Urolithin B vs Urolithin A

Anabolic signal vs. mitochondrial cleanup: muscle growth or deep recovery?

Effectiveness Profile

Urolithin B
Urolithin A

At a Glance

 Urolithin BUrolithin A
TypeLongevityLongevity
Legal statusResearchOTC
Half-life17–22 hours (aglycone, class-extrapolated); 25–58 hours (glucuronide conjugates)~17–22 hours (glucuronide conjugate); free UA short
Preferred routeOralOral
Dose frequencyonce-dailyonce-daily
Beginner dose50–100 mg250–500 mg
Intermediate dose250–500 mg500–1000 mg
Advanced dose500–1000 mg1000–1000 mg
Cycle length8–16 wks8–52 wks
Bioavailability5%15%
Time to peak6h6h
Active duration24h24h
StorageRoom temperature, desiccated, protected from light; hygroscopic powderRoom temperature, dry, protected from light
PCT requiredNoNo
Ancillaries requiredNoNo
Safe for womenYesYes

Verdict

Urolithin B wins for: direct muscle hypertrophy signaling via AR/mTORC1, suppressing atrogenes during cuts or immobilization, and stacking cleanly with creatine for recomp-focused protocols. It is the only urolithin with in vivo hypertrophy data and measurable anabolic effects—even if those effects are modest (creatine-range).

Urolithin A wins for: mitochondrial health, endurance, and long-term recovery through clinically validated mitophagy induction. UA is evidence-backed for improving muscle endurance and mitochondrial function in chronic protocols and is the clear leader for longevity or master's protocols where fatigue resistance and organ health are the goals.

Pick A or B?

Pick Urolithin B if:

  • The protocol targets muscle mass retention or slow-burn hypertrophy during cuts, TRT, or immobilization
  • A non-suppressive, anabolic adjunct is desired without the SARM/PED baggage
  • The goal is to suppress muscle atrogenes (MuRF1/atrogin-1) for anti-catabolic effect
  • Stacking with creatine, high-protein diets, or minimal-AAS cycles is the plan
  • Hands are tied on UA-type mitophagy focus, but muscle signal is wanted

Pick Urolithin A if:

  • Deep mitochondrial health and muscle endurance are primary (e.g., high-volume training, master's protocols)
  • The priority is long-term recovery support with human RCT and biopsy data
  • Stacking for longevity anti-aging (NAD+, rapa, etc.) is core to the protocol
  • High baseline fatigue or slow recovery is limiting progression
  • The user lacks the gut microbiome for natural dietary conversion and needs direct UA delivery